Supply of specified pharmaceutical tablets for Indian Navy
Indian Navy · Mumbai · Pharmaceuticals · open
Key facts
- Published: 07 Aug 2026
- Closing date: 17 Aug 2026
- Status: open
- Ministry: Ministry of Defence
- Department: Department of Military Affairs
Description
Tender for the supply of various pharmaceutical tablets including GLICLAZIDE, METFORMIN, SILODOSIN, DUTASTERIDE, TADALAFIL, TOPIRAMATE, PIRFENIDONE, and MEBEVERINE HCL, with a total quantity of 90000 units, issued by the Indian Navy under the Ministry of Defence.
Eligibility & requirements
- Past performance: 20%
- Startup relaxation: Yes
- MSE relaxation: Yes
- Documents required: Experience proof, Turnover proof, OEM authorization
Commercial terms
- Bid type: Two Packet Bid
- Evaluation: Item wise evaluation
- Make in India (MII): Yes
- MSE preference: Yes
Line items (1)
- Pharmaceutical tablets including GLICLAZIDE, METFORMIN, SILODOSIN, DUTASTERIDE, TADALAFIL, TOPIRAMATE, PIRFENIDONE, MEBEVERINE HCL — Qty: 90000 unit
1 tender document(s) available — sign up to download.